Cost-effectiveness of selected interventions for hearing impairment in Africa and Asia: A mathematical modelling approach

被引:19
作者
Baltussen, R. [1 ]
Smith, A. [2 ]
机构
[1] Radboud Univ Nijmegen, Dept Publ Hlth Int Hlth, Med Ctr, NL-6500 HB Nijmegen, Netherlands
[2] London Sch Hyg & Trop Med, Int Ctr Eye Hlth, London WC1, England
关键词
Costs; Economic analysis; Cost-effectiveness; Hearing impairment; Deafness; Modelling; WORLD;
D O I
10.1080/14992020802538081
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
The purpose of this paper was to present estimates of costs and effects of selected interventions for hearing impairment in Africa and Asia. The method used mathematical simulation models on the basis of WHO burden of disease information, and WHO-CHOICE costing databases. Findings showed that in both regions, screening strategies for hearing impairment and delivery of hearing aids cost between I$1000 and I$1600 per DALY, with passive screening being the most efficient intervention. Active screening at schools and in the community are somewhat less cost-effective. In the treatment of chronic otitis media, aural toilet in combination with topical antibiotics costs is more efficient than aural toilet alone, and costs between I$11 and I$59 in both regions. The treatment of meningitis with ceftriaxone costs between I$55 and I$217 at low coverage levels, in both regions. In more absolute terms, the vast majority of all considered intervention strategies are cost-effective strategies according to international benchmarks, in both regions concerned. In conclusion, various strategies are economically attractiv;e to reduce the disease burden of hearing impairment around the world.
引用
收藏
页码:144 / 158
页数:15
相关论文
共 30 条
[1]   Econometric estimation of country-specific hospital costs [J].
Taghreed Adam ;
David B Evans ;
Christopher JL Murray .
Cost Effectiveness and Resource Allocation, 1 (1)
[2]  
[Anonymous], 2001, MACR HLTH INV HLTH E
[3]  
Arslan E, 1996, SCAND AUDIOL, V25, P35
[4]  
Baltussen R, 2004, B WORLD HEALTH ORGAN, V82, P338
[5]   Cost-effectiveness of trachoma control in seven world regions [J].
Baltussen, RMRM ;
Sylla, M ;
Frick, KD ;
Mariotti, SR .
OPHTHALMIC EPIDEMIOLOGY, 2005, 12 (02) :91-101
[6]   A generic model for the assessment of disease epidemiology: The computational basis of DisMod II [J].
Jan J Barendregt ;
Gerrit J van Oortmarssen ;
Theo Vos ;
Christopher JL Murray .
Population Health Metrics, 1 (1)
[7]   STRATEGY FOR PREVENTION OF DEAFNESS IN THE THIRD-WORLD [J].
BROBBY, GW .
TROPICAL DOCTOR, 1989, 19 (04) :152-154
[8]  
Cook J, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P953
[9]  
Drummond MF, 2005, Methods for The Economic Evaluation of Health Care Programmes
[10]  
*ERC, INT DRUG PRIC IND GU